Pegulicianine Acetate

CHEMBL4594345 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

— g/mol

LogP

—

Phase

4

A fluorescent imaging agent used during surgery to help surgeons visualize cancer tissue in real time, improving the ability to remove breast cancer tumors with clear margins. It is activated by a special light source used intraoperatively.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A fluorescent imaging agent used during surgery to help surgeons visualize cancer tissue in real time, improving the ability to remove breast cancer tumors with clear margins. It is activated by a special light source used intraoperatively.

Yes, Pegulicianine Acetate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL4594345. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Pegulicianine Acetate PillFYI'da

Hızlı Veriler

Dış Bağlantılar

ChEMBL CHEMBL4594345

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.